Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 80 /hr
Hire Dr. Ana K.
USD 80 /hr

PhD in Genetics; Genetic counselor; Expert in cancer genetics, Cancer research and Bioethics

Profile Summary
Subject Matter Expertise
Writing Clinical Trial Documentation, Technical Writing, Newswriting
Research Systematic Literature Review, Secondary Data Collection
Work Experience

Head of Department for genetic counseling and hereditary cancers

Institute for Oncology and Radiology of Serbia

January 2019 - Present

Assistant Research Professor

Institute for Oncology and Radiology of Serbia

January 2014 - Present


Master of Science in Bioethics

Clarkson University and Mount Sinai Hospital, Department of Bioethics, Schenectady, NY 12308, USA

January 2014 - January 2017

PhD in Genetics

School of Biology, University of Belgrade, Serbia

January 2009 - January 2014

Master of Science in Molecular Biology and Physiology

School of Biology, University of Belgrade, Serbia

January 2003 - January 2009

  • Certification details not provided.
Jakovljević, K., Matić, I.Z., Stanojković, T., Krivokuća, A., Marković, V., Joksović, M.D., Mihailović, N., Nićiforović, M., Joksović, L.(2017). Synthesis, antioxidant and antiproliferative activities of 1,3,4-thiadiazoles derived from phenolic acids . Bioorganic and Medicinal Chemistry Letters. 27. (16). p. 3709-3715.
Krivokuca, A., Dragos, V.S., Stamatovic, L., Blatnik, A., Boljevic, I., Stegel, V., Rakobradovic, J., Skerl, P., Jovandic, S., Krajc, M., et al.(2017). Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin . Familial Cancer. p. 1-7.
Cavic, M., Krivokuca, A., Boljevic, I., Brotto, K., Jovanovic, K., Tanic, M., Filipovic, L., Zee, M., Malisic, E., Jankovic, R., et al.(2016). Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia . Journal of B.U.ON. 21. (5). p. 1287-1295.
Krivokuca, A.M., Cavic, M.R., Malisic, E.J., Rakobradovic, J.D., Kolarevic-Ivankovic, D., Tomasevic, Z.I., Brankovic-Magic, M.V.(2016). Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women . International Journal of Biological Markers. 31. (3). p. e258-e263.
Malisic, E.J., Krivokuca, A.M., Boljevic, I.Z., Jankovic, R.N.(2015). Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women . Cancer Biomarkers. 15. (5). p. 685-691.
Krivokuca, A., Yanowski, K., Rakobradovic, J., Benitez, J., Brankovic-Magic, M.(2015). RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families . Cancer biomarkers : section A of Disease markers. 15. (6). p. 775-781.
Zec, M., Srdić-Rajić, T., Krivokuća, A., Janković, R., Todorović, T., Andelković, K., Radulović, S.(2014). Novel selenosemicarbazone metal complexes exert anti-tumor effect via alternative, caspase-independent Necroptotic cell death . Medicinal Chemistry. 10. (8). p. 759-771.
Krivokuca, A.M., Malisic, E.J., Dobricic, J.D., Brotto, K.V., Cavic, M.R., Jankovic, R.N., Tomasevic, Z.I., Brankovic-Magic, M.V.(2014). RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women . Familial Cancer. 13. (2). p. 173-180.
Cavic, M., Krivokuca, A., Spasic, J., Brotto, K., Malisic, E., Radosavljevic, D., Radulovic, S., Jankovic, R.(2014). The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence . Journal of B.U.ON. 19. (4). p. 1024-1028.
Malisic, E., Brotto, K., Krivokuca, A., Cavic, M., Malisic, E., Brotto, K., Krivokuca, A., Cavic, M., Jankovic, R.(2014). Overall human papilloma virus and types 16/18 prevalence in women with normal cervical cytology in Serbia: Is it time for human papillomavirus testing and/or vaccination? . Journal of B.U.ON. 19. (4). p. 973-979.
Dobričić, J., Krivokuća, A., Brotto, K., Mališić, E., Radulović, S., Branković-Magić, M.(2013). Serbian high-risk families: Extensive results on BRCA mutation spectra and frequency . Journal of Human Genetics. 58. (8). p. 501-507.
Filipovic, L., Arandelovic, S., Gligorijevic, N., Krivokuca, A., Jankovic, R., Srdic-Rajic, T., Rakic, G., Tesic, Z., Radulovic, S.(2013). Biological evaluation of transdichloridoplatinum(II) complexes with 3-and 4-acetylpyridine in comparison to cisplatin . Radiology and Oncology. 47. (4). p. 346-357.
Krivokuca, A., Dobricic, J., Brankovic-Magic, M.(2013). CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families . Journal of B.U.ON. 18. (3). p. 594-600.
Brotto, K., Malisic, E., Cavic, M., Krivokuca, A., Jankovic, R.(2013). The usability of allele-specific PCR and reverse-hybridization assays for KRAS genotyping in serbian colorectal cancer patients . Digestive Diseases and Sciences. 58. (4). p. 998-1003.
Jakovljevic, K., Malisic, E., Cavic, M., Krivokuca, A., Dobricic, J., Jankovic, R.(2012). KRAS and BRAF mutations in Serbian patients with colorectal cancer . Journal of B.U.ON. 17. (3). p. 575-580.
Jakovljević, K.V., Spasić, M.R., Mališić, E.J., Dobričić, J.D., Krivokuća, A.M., Janković, R.N.(2010). Comparison of phenol-based and alternative RNA isolation methods for gene expression analyses . Journal of the Serbian Chemical Society. 75. (8). p. 1053-1061.